Consortium Receives $8M to Investigate Molecular Roots of Extreme Aggression
By GenomeWeb,
GenomeWeb
| 09. 12. 2013
NEW YORK (GenomeWeb News) – The European Union has approved a project aimed at determining the causes of extreme aggressive behavior and is providing €6 million ($8 million) to the effort.
Called Aggressotype, the project seeks to find the molecular roots of extreme aggression in children with attention deficit hyperactivity disorder and other "conduct disorders," as well as in the general population. The total cost of the project is about €8.1 million, according to the grant application. The EU funding was awarded as part of the Seventh Framework Programme.
In the application, the researchers said that they will use existing data sets and acquire new data to build a "knowledge chain from molecule to behavior, investigating known and novel genes, gene networks, and their epigenetic interactions, and mapping their mode of action from the molecular via the cellular to the brain-circuit level."
The work, they added, is expected to result in new algorithms that may be useful in predicting aggressive behavior. The algorithms will be validated in existing longitudinal studies in children. Their predictive value for adults will also be...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
